1. Role: Director. Scope: Department. Date: 2019.
Grant H. Skrepnek, Ph.D., R.Ph.
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47105
Fax (4050 271-6430
Office CPB 214
Email grant-skrepnek@ouhsc.edu
Summary
I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Research
Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Publications & Presentations
- 56. Skrepnek G H, Sahai A, Antoine R. An Improved Minimum Mean Squared Error Estimate of the Square of the Normal Population Variance Using Computational Intelligence. Journal of Applied Mathematics and Bioinformatics. 2015; 5 : 53-65
57. Skrepnek G H, Thompson T C, Johnson E J. Debt and Taxes: Marginal Tax Rate Changes, Capital Structure, and Innovative Activity in the Biotechnology Sector. Journal of Commercial Biotechnology. 2015; 21 : 19-30
58. Skrepnek G H, Tate W R, Baker A F. Clinical and Economic Burden of Richter Syndrome in Inpatient Cases of Chronic Lymphocytic Leukemia within the United States, 2001-2010. Leukemia and Lymphoma. 2014; 55 : 834-840
59. Olvey E L, Guy M C, Chang J, Skrepnek G H. Cost-Effectiveness of Medication Therapy Management in Medicare Part-D Diabetic Enrollees. American Journal of Pharmaceutical Benefits. 2014; 6 : 147-156
60. Gilligan A, Skrepnek G H. Determinants of Life Expectancy in the Eastern Mediterranean Region. Health Policy and Planning. 2014
Grants
- 6. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.
7. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.
8. C2015602 - 1815 Medication Therapy Management, Tele-MTM. Non-federal. Start Date: 2019. End Date: 2020.
9. C7069901 - MTM Drug Utilization Review. Non-federal. Start Date: 2019. End Date: 2020.
10. C7070101 - Study of Oklahoma Medicaid Assessing Outcomes Associated with Long-Acting Injectable Antipsychotics. Non-federal. Start Date: 2019. End Date: 2020.
Awards and Honors
no results
Education
no results
Administrative Assignments
2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.